Literature DB >> 9500845

Regulatory effect of CD9 on calcium-stimulated phosphatidylserine exposure in Jurkat T lymphocytes.

W Li1, J F Tait.   

Abstract

Alteration in membrane-phosphatidylserine (PS) asymmetry occurs during lymphocyte apoptosis, but the mechanism and regulation of this process are not well understood. We investigated the possible involvement of CD9, a member of the tetraspan family of membrane proteins, in the PS-exposure process in Jurkat T cells; flow cytometry with FITC-annexin V was used to detect the PS-positive cells. We found that antibody to CD9 inhibited the prompt (within 5 min) PS exposure stimulated by calcium ionophore A23187, whereas it had no effect on resting cells. Antibodies against other control antigens (CD7, CD56, CD57, CD59, CD63, and CD71) had no effect on PS exposure in either resting or calcium-ionophore-treated cells. The inhibitory effect of anti-CD9 was dose dependent. The observed inhibitory effect appeared to be "all or none" at the cellular level: increasing antibody doses decreased the percentage of PS-positive cells, whereas the number of PS molecules exposed per positive cell was constant. The inhibitory effect was not blocked by co-incubation with other antibodies of the same isotype, arguing against a nonspecific effect via Fc receptors. The anti-CD9, however, did not block the delayed (8- to 24-h) PS exposure induced by apoptotic treatments such as ultraviolet light, cycloheximide, and actinomycin D, indicating that CD9 might act selectively on only some pathways leading to PS exposure. Our results suggest that lymphocyte PS exposure is regulated by multiple pathways and that signals regulating PS exposure can be delivered through cell-surface antigen CD9.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9500845     DOI: 10.1006/abbi.1997.0535

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Antibody cross-linking of human CD9 and the high-affinity immunoglobulin E receptor stimulates secretion from transfected rat basophilic leukaemia cells.

Authors:  A Higginbottom; I Wilkinson; B McCullough; F Lanza; D O Azorsa; L J Partridge; P N Monk
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

2.  FM1-43 reports plasma membrane phospholipid scrambling in T-lymphocytes.

Authors:  A Zweifach
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

3.  Evidence that cytosolic calcium increases are not sufficient to stimulate phospholipid scrambling in human T-lymphocytes.

Authors:  Georjeana A Wurth; Adam Zweifach
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

Review 4.  The ins and outs of phospholipid asymmetry in the plasma membrane: roles in health and disease.

Authors:  Bengt Fadeel; Ding Xue
Journal:  Crit Rev Biochem Mol Biol       Date:  2009 Sep-Oct       Impact factor: 8.250

5.  Deciphering the plasma membrane hallmarks of apoptotic cells: phosphatidylserine transverse redistribution and calcium entry.

Authors:  M C Martínez; J M Freyssinet
Journal:  BMC Cell Biol       Date:  2001-10-17       Impact factor: 4.241

6.  Synergistic effects of secretory phospholipase A2 from the venom of Agkistrodon piscivorus piscivorus with cancer chemotherapeutic agents.

Authors:  Jennifer Nelson; Kristen Barlow; D Olin Beck; Amanda Berbert; Nathan Eshenroder; Lyndee Francom; Mark Pruitt; Kina Thompson; Kyle Thompson; Brian Thurber; Celestine H-Y Yeung; Allan M Judd; John D Bell
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

7.  Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer.

Authors:  Carolina Soekmadji; James D Riches; Pamela J Russell; Jayde E Ruelcke; Stephen McPherson; Chenwei Wang; Chris M Hovens; Niall M Corcoran; Michelle M Hill; Colleen C Nelson
Journal:  Oncotarget       Date:  2016-08-08

Review 8.  CD9 Tetraspanin: A New Pathway for the Regulation of Inflammation?

Authors:  Carole Brosseau; Luc Colas; Antoine Magnan; Sophie Brouard
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.